Skip to main content
OpenTrials
Completed

NCT Number: NCT04619654

Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma

This study will examine the visual outcomes of subjects undergoing cataract surgery and minimally invasive glaucoma surgery with the implantation of a trifocal intraocular lens.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vold Vision P.L.L.C.

Fayetteville, Arkansas, 72764, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female subjects 45 years of age or older
  • A visually significant cataract
  • Diagnosis of mild OAG
  • Vertical C/D ratio of less than or equal to 0.8
  • VF characteristics consistent with glaucoma with mean deviation not worse than -6.00 dB and without fixation threatening scotoma AND/OR with nerve abnormalities consistent with glaucoma (rim notching, rim thinning, disc hemorrhage, nerve fiber layer loss)
  • Medicated IOP 25 of less than or equal to mmHg on 1-3 medications
  • If treatment naïve (before glaucoma treatment) IOP between 21 and 35 mmHg
  • Glaucoma must be judged as stable by investigator based on review of subject medical records
  • Stable VF at least 1 year prior to surgery
  • Stable nerve fiber layer at least 1 year prior to surgery
  • IOP stable on current medication regimen at least 3 months prior to surgery
  • Shaffer grade of greater than III in all quadrants
  • Potential of good best corrected visual acuity at distance in the investigator's judgement of at least 0.1 logMAR (20/25) postoperatively
  • Able and willing to comply with follow up visits
  • Understands and signs the informed consent

Exclusion criteria

  • Previous incisional glaucoma surgery or cilio-ablative surgery
  • Prior laser trabeculoplasty within 90 days of surgery
  • Pseudoexfoliative, angle closure, uveitic, congenital, traumatic, angle recession, or neovascular glaucoma.
  • Moderate glaucoma with VF mean deviation between -6.00 dB and -12.00 dB
  • Severe and/or progressive glaucoma defined as
  • VF mean deviation worse than -12.00 dB
  • Consistent worsening of visual field on review of subject medical records
  • Consistent and progressive thinning of nerve fiber layer on review of subject medical records
  • Uncontrolled IOP on maximum glaucoma medications
  • Historically poor IOP control with medical therapy
  • Severe focal notching of the optic nerve rim
  • Expectation for future need of incisional glaucoma surgery
  • Ocular pathology or other medical condition which, in the investigator's judgment places the subject at increased risk of complications or significant vision loss during study period.
  • Ocular pathology that in the investigator's judgment may impact visual acuity postoperatively, i.e. significant ocular surface disease, corneal scarring, blepharitis, epiretinal membrane, macular degeneration, history of significant ocular trauma with sequela, etc.
  • Pregnant or breastfeeding women
  • Prior refractive surgery e.g. LASIK, RK, PRK, etc.

Treatment and study plan

Cataract surgery with implantation of trifocal IOL combined with trabecular scaffold

Procedure

Cataract surgery with implantation of the PanOptix IOL combined with minimally invasive glaucoma surgery utilizing the Hydrus Microstent

Primary outcomes

  1. Mean Photopic Monocular Best Corrected Distance Visual Acuity (DCVA) (4 meters) logMAR

    Time frame: 3 months

Secondary outcomes

  1. Mean Photopic Monocular Best Distance Corrected Intermediate Visual Acuity (DCIVA) (60 cm) logMAR

    Time frame: 3 months

  2. Mean Photopic Monocular Best Distance Corrected Near Visual Acuity (DCNVA) (40 cm) logMAR

    Time frame: 3 months

  3. Mean Photopic Monocular Uncorrected Distance Visual Acuity (UCDVA) (4 meters) logMAR

    Time frame: 3 months

  4. Mean Photopic Monocular Uncorrected Intermediate Visual Acuity (UCIVA) (60 cm) logMAR

    Time frame: 3 months

  5. Mean Photopic Monocular Uncorrected Near Visual Acuity (UCNVA) (40 cm) logMAR

    Time frame: 3 months

  6. Mean Photopic Binocular Best Corrected Distance Visual Acuity (DCVA) (4 meters) logMAR

    Time frame: 3 months

  7. Mean Photopic Binocular Best Distance Corrected Intermediate Visual Acuity (DCIVA) (60 cm) logMAR

    Time frame: 3 months

  8. Mean Photopic Binocular Best Distance Corrected Near Visual Acuity (DCNVA) (40 cm) logMAR

    Time frame: 3 months

  9. Mean Photopic Binocular Uncorrected Distance Visual Acuity (UCDVA) (4 meters) logMAR

    Time frame: 3 months

  10. Mean Photopic Binocular Uncorrected Intermediate Visual Acuity (UCIVA) (60 cm) logMAR

    Time frame: 3 months

  11. Mean Photopic Binocular Uncorrected Near Visual Acuity (UCNVA) (40 cm) logMAR

    Time frame: 3 months

  12. Mean Photopic Binocular Best Corrected Distance Low Contrast Visual Acuity (25%) (4 meters) logMar

    Time frame: 3 months

  13. Mean Mesopic Binocular Best Corrected Distance Low Contrast Visual Acuity (25%) (4 meters) logMar

    Time frame: 3 months

Other outcomes

  1. Mean Postoperative Refractive Spherical Equivalent

    Time frame: 3 months

  2. Absolute Prediction Error

    Time frame: 3 months

    Difference from postoperative refraction from preoperative biometry

  3. Quality of Vision Questionnaire (QoV)

    Time frame: 3 months

    Grading of dysphotopsia

  4. Spectacle-Dependence questionnaire

    Time frame: 3 months

    Gauging spectacle independence postoperatively

  5. Mean preoperative IOP versus postoperative IOP

    Time frame: 3 months

  6. Glaucoma Mean preoperative medications versus postoperative medications

    Time frame: 3 months

  7. Percentage of patients with an IOP of less than or equal to18 mmHg and less than or equal to15 mm Hg on no glaucoma medications postoperatively

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Vold Vision P.L.L.C

Other

Collaborators

  • Alcon Research

Registry information

Official study title

Visual Acuity, Refractive Predictability, and Patient Reported Quality of Vision in Subjects Implanted With a Trifocal IOL With Stable Mild Open-Angle Glaucoma Undergoing Concurrent Minimally Invasive Glaucoma Surgery

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Nov 6, 2020
Registry last updated
Nov 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.